Novo Nordisk A/S (ADR) news

   Watch this stock
Showing stories 11 - 20 of about 85   

Articles published

NVO 47.75 -0.02 (-0.04%)
price chart
Novo Nordisk A/S: Share repurchase programme
Headquartered in Denmark, Novo Nordisk employs approximately. 40,700 employees in 75 countries, and markets its products in more than 180 countries.
Related articles »  
ADR Shares End Higher; WPP Shares Active
The chief executive of insulin-maker Novo Nordisk A/S (NVO, NOVO-B.KO) said he hasn't plans to make any big acquisitions, suggesting his company will be sitting out the frenzy of deal-making that has convulsed the global pharmaceutical industry this year.
Related articles »  
Stocks in Focus � Novo Nordisk, (NYSE:NVO), NextEra Energy, (NYSE:NEE ...
Novo Nordisk A/S (ADR) (NYSE:NVO) decreased -1.24% and closed at $45.39 in the last trading session with the overall traded volume of 1.61 million shares, versus the average volume of 977,685 shares.
Related articles »  
MannKind Corporation: Not Everyone's Bearish On Afrezza
Also, there are concerns that Eli Lilly and Co (NYSE:LLY) and Novo Nordisk A/S (ADR) (NYSE:NVO) will aggressively work to keep MannKind from successfully taking share from them in the mealtime insulin market.
Guru Stocks at 52-Week Lows: CHL, TM, SNY, NVO, TSM
The prices of Novo Nordisk A/S (NVO) shares have declined to close to the 52-week low of $45.96, which is 32.3% off the 52-week high of $265.30.
Related articles »  
Stocks in News : Altria Group Inc. (NYSE:MO), Eaton (NYSE:ETN), Vodafone ...
With 14-1 votes, the FDA committee concluded that the benefit-risk assessment of the drug was favourable for individuals with severe weight problems, the Danish group said.
Related articles »  
Hot Stock List: Halliburton Company (NYSE:HAL), CBOE (NASDAQ:CBOE ...
Novo Nordisk A/S (NYSE:NVO) on 8 August reported second-quarter 2014 earnings of 48 cents per American Depository Receipt (:ADR), higher than the year-ago earnings of 44 cents. In the reported quarter, revenues increased 6% to $3.9 billion year over ...
Novo Nordisk A/S initiates share repurchase programme
Novo Nordisk A/S maintains FY 2014 outlook